Antibodies to Escherichia coli Outer Membrane Porin C in the Absence of Anti–Saccharomyces cerevisiae Antibodies and Anti‐neutrophil Cytoplasmic Antibodies Are an Unreliable Marker of Crohn Disease and Ulcerative Colitis
- 1 October 2007
- journal article
- research article
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 45 (4), 409-413
- https://doi.org/10.1097/mpg.0b013e31812f7f6e
Abstract
Objectives: Antibodies to Escherichia coli outer membrane porin C (anti-OmpC), Saccharomyces cerevisiae, and neutrophil-specific nuclear antigens are associated with inflammatory bowel disease (IBD) in children and young adults. We hypothesized that anti-OmpC, in the absence of anti–S cerevisiae antibodies (ASCA) and antineutrophil cytoplasmic antibodies (ANCA), is an assay that overestimates the presence of Crohn disease (CD) and ulcerative colitis (UC). Patients and Methods: A retrospective review of patients evaluated at our institution between January 2002 and June 2006 revealed that 170 had serodiagnostic immunological assays performed as part of an evaluation for possible IBD. The assays were screened for a pattern in which anti-OmpC was present in the absence of ASCA and ANCA. Results: Seven patients between 3 and 20 years of age were discovered to be positive for anti-OmpC but negative for ASCA and ANCA. These patients were determined to have significant medical conditions without combined radiographic, endoscopic, or histological evidence of IBD. Despite the reported 85% positive predictive value of anti-OmpC for IBD, none of the 7 patients with isolated anti-OmpC had a diagnosis of CD or UC. Conclusions: Anti-OmpC, in the absence of ASCA and ANCA, is a serological pattern noted in a subset of medically complex cases in children and young adults without CD or UC.Keywords
This publication has 6 references indexed in Scilit:
- Use of Serologic Markers as a Screening Tool in Inflammatory Bowel Disease Compared With Elevated Erythrocyte Sedimentation Rate and AnemiaPediatrics, 2007
- Positive and Negative Predictive Values: Use of Inflammatory Bowel Disease Serologic MarkersAmerican Journal of Gastroenterology, 2006
- Serum Immune Responses Predict Rapid Disease Progression among Children with Crohn's Disease: Immune Responses Predict Disease ProgressionAmerican Journal of Gastroenterology, 2006
- Serologic Testing with ANCA, ASCA, and Anti-OmpC in Children and Young Adults with Crohn's Disease and Ulcerative Colitis: Diagnostic Value and Correlation with Disease PhenotypeAmerican Journal of Gastroenterology, 2004
- Selected loss of tolerance evidenced by Crohn's disease–associated immune responses to auto- and microbial antigensGastroenterology, 2002
- Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel diseaseAmerican Journal of Gastroenterology, 2001